Do α₂-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal?

Affiliations

Editorial

Michael Gottlieb et al. Ann Emerg Med. 2017 Jun.

. 2017 Jun;69(6):740-742.

doi: 10.1016/j.annemergmed.2016.09.003. Epub 2016 Nov 4.

¹ Department of Emergency Medicine, Rush University Medical Center, Chicago, IL.

No abstract available

Comment in

In reply.
Gottlieb M, Gore K. Gottlieb M, et al. Ann Emerg Med. 2018 Feb;71(2):268-269. doi: 10.1016/j.annemergmed.2017.09.034. Epub 2018 Feb 5. Ann Emerg Med. 2018. PMID: 29447874 No abstract available.
A Commentary: Do α2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal?
Flemming H, Hoffman R. Flemming H, et al. Ann Emerg Med. 2018 Feb;71(2):268. doi: 10.1016/j.annemergmed.2017.09.033. Epub 2018 Feb 5. Ann Emerg Med. 2018. PMID: 29447875 No abstract available.

Alpha₂-adrenergic agonists for the management of opioid withdrawal.
Gowing L, Farrell M, Ali R, White JM. Gowing L, et al. Cochrane Database Syst Rev. 2016 May 3;2016(5):CD002024. doi: 10.1002/14651858.CD002024.pub5. Cochrane Database Syst Rev. 2016. PMID: 27140827 Free PMC article.